Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Cochlear implantation following treatment for medulloblastoma
J. Thomas Roland
, Maura Cosetti
, Tracey Liebman
, Susan Waltzman
, Jeffrey C. Allen
Research output
:
Contribution to journal
›
Article
›
peer-review
13
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cochlear implantation following treatment for medulloblastoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adjuvant Chemotherapy
14%
Central Nervous System Tumors
14%
Chemoradiation
14%
Chemotherapy
14%
Chronic Ear Disease
14%
Cochlear Implant
14%
Cochlear Implant Electrode
14%
Cochlear Implantation
100%
Course Performance
14%
Craniospinal Radiotherapy
14%
Diagnosis Treatment
14%
Disease Course
14%
Electrode Array
14%
External Beam Radiation
14%
Full Insertion
14%
Intraoperative Complications
14%
Mastoid
14%
Medulloblastoma
100%
Middle Ear
14%
Middle Ear Disease
14%
Middle Ear Pathology
14%
Multi-agent
14%
Multiagent Chemotherapy
14%
Oncological Treatment
42%
Operative
14%
Operative Closure
14%
Otologic
28%
Otologic Complications
14%
Outcome Assessment
14%
Pediatric Medulloblastoma
28%
Pediatric Tumors
14%
Performance Data
57%
Postoperative Course
14%
Profound Sensorineural Hearing Loss
42%
Progress Management
14%
Radiation Chemotherapy
14%
Retrospective Chart Review
14%
Significant Benefit
14%
Support-significant
14%
Surgical Excision
14%
Surgical Resection
14%
Surgical Treatment
14%
Surgical Wound Dehiscence
14%
Tumor Surveillance
14%
Medicine and Dentistry
Adjuvant Chemotherapy
14%
Central Nervous System
14%
Chemoradiotherapy
14%
Chronic Ear Disease
14%
Cochlear Implant
28%
Cochlear Implantation
100%
Craniospinal Irradiation
14%
Ear Pathology
14%
External Beam Radiotherapy
14%
Malignant Neoplasm
14%
Medulloblastoma
100%
Middle Ear
28%
Middle Ear Disease
14%
Neoplasm
14%
Outcome Assessment
14%
Pediatrics
42%
Peroperative Complication
14%
Primary Outcome
14%
Sensorineural Hearing Loss
42%
Sequela
28%
Wound Dehiscence
14%